Abstract
Human asthma is on the rise worldwide. The necessity to develop effective treatments against it requires an organized effort which covers every aspect of the disease from the pathological alterations via the genetic background to the use and development of active remedies. In these processes animal experiments have served an indispensable role. As asthma is not a natural disease in the animal kingdom the variety for artificially established animal models is quite wide. The possible selection ranges from the laboratory mouse to the horse, it includes ferret and sheep and even favorite pets such as cats and dogs. The large number of the models indicates that to some extent they might not be appropriate or it means that there is no generally accepted model of human asthma. Whatever the reason for this diversity animal models helped us to understand the detailed pathogenesis of some aspects of the disease, they helped us to develop compounds which are more active then previously used ones, and these models proved to us that human asthma is a unique, possibly species-specific disease the eradication of which requires a huge effort. This enormous task should include the collaboration of the clinical and basic research for the development of improved, advanced animal models, which in turn could strengthen our understanding about human asthma.
Keywords: Asthma, allergic reaction, airway hyperresponsiveness, inflammation, remodeling, animal models
Current Pharmaceutical Design
Title: Current Animal Models of Bronchial Asthma
Volume: 12 Issue: 25
Author(s): I. Kurucz and I. Szelenyi
Affiliation:
Keywords: Asthma, allergic reaction, airway hyperresponsiveness, inflammation, remodeling, animal models
Abstract: Human asthma is on the rise worldwide. The necessity to develop effective treatments against it requires an organized effort which covers every aspect of the disease from the pathological alterations via the genetic background to the use and development of active remedies. In these processes animal experiments have served an indispensable role. As asthma is not a natural disease in the animal kingdom the variety for artificially established animal models is quite wide. The possible selection ranges from the laboratory mouse to the horse, it includes ferret and sheep and even favorite pets such as cats and dogs. The large number of the models indicates that to some extent they might not be appropriate or it means that there is no generally accepted model of human asthma. Whatever the reason for this diversity animal models helped us to understand the detailed pathogenesis of some aspects of the disease, they helped us to develop compounds which are more active then previously used ones, and these models proved to us that human asthma is a unique, possibly species-specific disease the eradication of which requires a huge effort. This enormous task should include the collaboration of the clinical and basic research for the development of improved, advanced animal models, which in turn could strengthen our understanding about human asthma.
Export Options
About this article
Cite this article as:
Kurucz I. and Szelenyi I., Current Animal Models of Bronchial Asthma, Current Pharmaceutical Design 2006; 12 (25) . https://dx.doi.org/10.2174/138161206778194169
DOI https://dx.doi.org/10.2174/138161206778194169 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanoparticles Adjuvants in Allergology: New Challenges and Pitfalls
Current Pharmaceutical Design A Study of Applications of Machine Learning Based Classification Methods for Virtual Screening of Lead Molecules
Combinatorial Chemistry & High Throughput Screening Association of Common Variants in the IL-33/ST2 Axis with Ischemic Stroke
Current Neurovascular Research Obesity and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Practical Approach to Children Presenting with Eosinophila and Hypereosinophilia
Current Pediatric Reviews The Cancer Hygiene Hypothesis: From Theory to Therapeutic Helminths
Current Cancer Therapy Reviews Substitute and Add-on Devices Used in Inhalation Therapy: is it Safe to Recommend Replacing the Ventolin™ Actuator with the Sports-Haler™
Drug Delivery Letters Editorial (Thematic Issue: Nutrition and Immunology in Diabetes, Cancer and Infectious Diseases)
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry Management Options in Childhood Asthma – What is the Current Evidence on which Treatment is Based?
Current Pediatric Reviews Modified Pulsincap of Ibuprofen - A Novel Approach for Chronotherapy
Current Drug Delivery Purine Derivatives as Ligands for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens
Current Medicinal Chemistry Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Premenstrual Asthma: A Myth or a Reality?
Current Respiratory Medicine Reviews Metabolic Syndrome the Gynecologist’s Approach
Current Women`s Health Reviews Poly(ADP-ribose)polymerase Inhibition - Where Now?
Current Medicinal Chemistry Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality
Current Drug Targets Association of Metabolic Syndrome and Asthma Status: A Prospective Study from Guilan Province, Iran
Endocrine, Metabolic & Immune Disorders - Drug Targets